Applied DNA Sciences Statistics
Total Valuation
APDN has a market cap or net worth of $10.01 million. The enterprise value is $4.32 million.
Important Dates
The next confirmed earnings date is Thursday, February 13, 2025, after market close.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
APDN has 52.29 million shares outstanding. The number of shares has increased by 506.64% in one year.
| Current Share Class | 52.29M |
| Shares Outstanding | 52.29M |
| Shares Change (YoY) | +506.64% |
| Shares Change (QoQ) | +156.63% |
| Owned by Insiders (%) | 7.20% |
| Owned by Institutions (%) | 6.53% |
| Float | 41.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| Forward PS | 1.85 |
| PB Ratio | 0.22 |
| P/TBV Ratio | 1.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.36 |
| Quick Ratio | 2.83 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -102.43% and return on invested capital (ROIC) is -110.83%.
| Return on Equity (ROE) | -102.43% |
| Return on Assets (ROA) | -66.30% |
| Return on Capital (ROIC) | -110.83% |
| Revenue Per Employee | $71,488 |
| Profits Per Employee | -$150,534 |
| Employee Count | 48 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 6.28 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.41% in the last 52 weeks. The beta is 0.38, so APDN's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -98.41% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 1.38 |
| Relative Strength Index (RSI) | 46.88 |
| Average Volume (20 Days) | 5,701,370 |
Short Selling Information
The latest short interest is 5.03 million, so 9.61% of the outstanding shares have been sold short.
| Short Interest | 5.03M |
| Short Previous Month | 5.30M |
| Short % of Shares Out | 9.61% |
| Short % of Float | 12.15% |
| Short Ratio (days to cover) | 0.47 |
Income Statement
In the last 12 months, APDN had revenue of $3.43 million and -$7.23 million in losses. Loss per share was -$1.82.
| Revenue | 3.43M |
| Gross Profit | 1.02M |
| Operating Income | -14.02M |
| Pretax Income | -7.29M |
| Net Income | -7.23M |
| EBITDA | -13.33M |
| EBIT | -14.02M |
| Loss Per Share | -$1.82 |
Full Income StatementBalance Sheet
The company has $6.43 million in cash and $739,161 in debt, giving a net cash position of $5.69 million or $0.11 per share.
| Cash & Cash Equivalents | 6.43M |
| Total Debt | 739,161 |
| Net Cash | 5.69M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 8.97M |
| Book Value Per Share | 0.89 |
| Working Capital | 5.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.71 million and capital expenditures -$407,904, giving a free cash flow of -$14.12 million.
| Operating Cash Flow | -13.71M |
| Capital Expenditures | -407,904 |
| Free Cash Flow | -14.12M |
| FCF Per Share | -$0.27 |
Full Cash Flow StatementMargins
Gross margin is 29.63%, with operating and profit margins of -408.72% and -203.78%.
| Gross Margin | 29.63% |
| Operating Margin | -408.72% |
| Pretax Margin | -206.57% |
| Profit Margin | -203.78% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -506.64% |
| Shareholder Yield | -506.64% |
| Earnings Yield | -72.19% |
| FCF Yield | -141.06% |
Analyst Forecast
The average price target for APDN is $1.50, which is 683.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.50 |
| Price Target Difference | 683.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on April 25, 2024. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Apr 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
APDN has an Altman Z-Score of -35.34 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35.34 |
| Piotroski F-Score | 1 |